Skip to Content

Tools

Report Releases

Latest Report

Policy Issues in the Development of Personalized Medicine in Oncology. Workshop Summary

Released: February 8, 2010
As cancer care becomes more personalized, patients will receive preventive or therapeutic interventions based on their susceptibilities or predicted responses. But before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of policy issues. To explore these policy challenges, the National Cancer Policy Forum held this workshop in June 2009.

Most Viewed Report

Initial National Priorities for Comparative Effectiveness Research

Released: June 30, 2009
Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options. Comparative effectiveness research (CER) identifies what works best for which patients under what circumstances. Congress, in the American Recovery and Reinvestment Act (ARRA) of 2009, tasked the Institute of Medicine (IOM) to recommend national priorities for research questions to be addressed by CER and supported by ARRA funds. In its 2009 report, Initial National Priorities for Comparative Effectiveness Research, the authoring committee establishes a working definition of CER, develops a priority list of research topics, and identifies the necessary requirements to support a robust and sustainable CER enterprise.

Stay up to date!